VIM and oral cavity squamous cell carcinoma: Silencing TET1 increases cisplatin sensitivity by altering the expression of multiple genes in various pathological conditions including vimentin in OVCA [37], and o6-methylguanine-DNA methyltransferase (MGMT) in oral squamous cell carcinoma (OSCC) [56].